4//SEC Filing
Spear Matthew A. 4
Accession 0001209191-21-068629
CIK 0001661460other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 8:38 PM ET
Size
6.9 KB
Accession
0001209191-21-068629
Insider Transaction Report
Form 4
Spear Matthew A.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-06$1.32/sh+10,000$13,220→ 61,485 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-06−10,000→ 70,861 totalExercise: $1.32Exp: 2026-06-19→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option is fully vested and exercisable.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001766302
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 8:38 PM ET
- Size
- 6.9 KB